"Identification of FDA approved drugs and nucleoside analogues as potential ..."

Atul Kumar Singh et al. (2021)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOMED.2020.104185

access: closed

type: Journal Article

metadata version: 2022-10-02

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cbm/SinghKPSGK21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/SinghKPSGK21
Atul Kumar Singh, Prem Prakash Kushwaha, Kumari Sunita Prajapati, Mohd Shuaib, Sanjay Gupta, Shashank Kumar:
Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study. Comput. Biol. Medicine 130: 104185 (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.